LwaCas13a indiscriminately targets the human transcriptome
Open Access
- 17 April 2026
- journal article
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 10, 242
Abstract
Background Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 13a (Cas13a) has been described as a superior tool to short-interfering RNAs (siRNAs) for specific gene silencing. Cas13 targets RNAs through Watson-Crick binding of the target CRISPR RNA (crRNA) and activation of nuclease activity. In bacteria, once Leptotrichia wadei Cas13a (LwCas13a) has cut its specific target, the trans-collateral activity of the protein degrades any single-stranded RNA present in the cell independent of its sequence or homology to the crRNA. This transcollateral activity has been reported to be absent in mammalian cells. Therefore, in this study, we aimed to downregulate mRNAs expression in mammalian cells (HaCaT and HEK293T) using LwaCas13a. Methods We developed a doxycycline-inducible system to express LwaCas13a in HEK293T cells. The off-target activity of LwaCas13a in HEK293T cells was analyzed using RNA-seq. Results In this study, we observed that activation of LwaCas13a in HEK293T cells led to non-specific targeting of RNAs, which caused cell toxicity and death. Conclusion This study provides evidence of the off-target activity of LwaCas13a in HEK293T cells, making it an unsuitable tool for the specific downregulation of RNAs.Keywords
Funding Information
- Wellcome Trust (203128/A/16/Z)
- University of Manchester FBMH Facilitating excellence fund
- MRC (MR/X023397/1)
- MRC (MR/P009700/1)
This publication has 23 references indexed in Scilit:
- Characterizing the collateral activity of CRISPR/Cas13 in mammalian cells: Implications for RNA editing and therapeutic applicationsInternational Journal of Biological Macromolecules, 2024
- A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome EngineeringMolecular Biotechnology, 2022
- N-Terminal Amino Acids Determine KLF4 Protein Stability in 2A Peptide-Linked Polycistronic Reprogramming ConstructsStem Cell Reports, 2020
- Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 SystemsMolecular Cell, 2019
- The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma CellsAdvanced Science, 2019
- Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophageNature, 2019
- Leaky Expression of the TET-On System Hinders Control of Endogenous miRNA AbundanceBiotechnology Journal, 2018
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR EffectorsCell, 2018
- RNA targeting with CRISPR–Cas13Nature, 2017
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013